Previous 10 |
Looks like another red day for Wall Street today heading down for a fourth-straight session. Wall Street is still making up its mind on the fresh inflation data and third-quarter earnings reports. The broad index dipped about 0.2% after opening slightly higher. The Dow Jones Industrial Averag...
Shares of Jasper Therapeutics (NASDAQ: JSPR) were up 117.8% as of 10:39 a.m. EDT on Wednesday after the company received some affection from Wall Street . Oppenheimer initiated coverage of the small clinical-stage biopharmaceutical company with an outperform rating and a hug...
Gainers: Jasper Therapeutics JSPR +114%, Clarus Therapeutics (NASDAQ:CRXT) +45%, Alimera Sciences ALIM +19%, Revance Therapeutics RVNC +13%, Recursion Pharmaceuticals (NASDAQ:RXRX) +12%. Losers: NeuroOne Medical Technologies NMTC -25%, Ne...
NeuroBo Pharmaceuticals (NASDAQ:NRBO) +23% announces positive recommendation from independent data safety monitoring committee of phase 2/3 clinical trial of ANA001 in hospitalized patients with moderate to severe COVID-19 Jasper Therapeutics (NASDAQ:JSPR) +22% after bullish ca...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday! Source: Shutterstock We’ve got plenty to talk abou...
This morning DOW has shed over 100 points and it looks like October will be no different than the volatile September. A surge in rates to end September knocked highly valued tech stocks. The 10-year Treasury yield was higher Monday, trading around 1.49%. Let’s take a look at some of th...
Xenon Pharmaceuticals XENE +90% on positive XEN1101 data in mid-stage focal epilepsy study Elmira Savings Bank ESBK +66% Community Bank System to buy Elmira Savings Bank in $82.8M all cash deal OpGen OPGN +30% after announcing preliminary Q3 revenue ahead of expe...
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
Jasper Therapeutics Inc. Website:
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneou...
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CS...
2024-06-16 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...